Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
OSR Holdings, Inc. is a global healthcare holding company operating through subsidiaries focused on developing innovative therapies and medical devices. Its core businesses include oral T-cell immunotherapies for cancer, design-augmented biologics for age-related degenerative diseases, and neurovascular intervention device distribution in Korea. OSR leverages scientific expertise and strategic partnerships to advance drug development and commercialization, targeting unmet medical needs with a diversified, risk-managed portfolio across major healthcare markets.
This description was generated via AI from an annual report. Updated about 1 year ago.